Telemedicine Growth in the MENA Region: A Digital Healthcare Revolution

By Melike Belenli Gümüş

October 23, 2024

A recent article provides a comprehensive overview of the growing adoption of telemedicine and its significant impact in the Middle East and North Africa (MENA) region. Telemedicine has become increasingly essential as it transforms healthcare delivery, particularly in remote and underserved areas. Here are the key points:

Telemedicine Growth in the MENA

The telehealth market in the MENA region is expected to grow significantly, with a projected Compound Annual Growth Rate (CAGR) of 31.57% from 2024 to 2030. This growth is driven by improved internet connectivity, the proliferation of smartphones, and government initiatives to promote telemedicine.

Impact of the COVID-19 Pandemic

The COVID-19 pandemic acted as a catalyst for the adoption of telemedicine. Prior to the pandemic, telehealth utilisation was relatively low, but by April 2020, its use surged to 78 times higher than pre-pandemic levels. This rapid increase highlighted the necessity of virtual care solutions, especially in rural areas with limited healthcare options.

Country-Specific Initiatives

Countries such as Saudi Arabia, the United Arab Emirates (UAE), and Egypt are at the forefront of this digital healthcare revolution. In the UAE, the telemedicine sector is thriving, driven by a tech-savvy population and government commitment to healthcare innovation. Kuwait has launched initiatives like the ‘Sehaty Online’ platform and a telemedical electronic portal as part of the “New Kuwait” national development plan for 2035.

Benefits of Telemedicine

Telemedicine offers numerous benefits, including convenience, as patients can access medical care from their homes. It is also cost-effective, reducing the need for physical visits to healthcare facilities. Moreover, telemedicine improves access to healthcare, particularly for individuals in rural and underserved areas where traditional healthcare facilities are limited, thereby enhancing overall healthcare accessibility.

Challenges

Despite the promising growth of telemedicine, several challenges persist. Protecting patient data remains a significant issue due to cybersecurity concerns. Regulatory barriers also pose a problem, as different regulatory requirements across various emirates and countries can hinder the expansion of telehealth services. There is a need for better integration of telehealth services into the existing healthcare infrastructure. Moreover, the growing use of telemedicine necessitates training healthcare professionals in these technologies to ensure effective implementation and use.

Future Directions

The future of telemedicine in the MENA region looks promising with continued investment in digital health technologies and growing acceptance among patients and providers. Governments and healthcare organisations are working to overcome existing challenges, and telemedicine is revolutionising healthcare delivery, making it more accessible, efficient, and patient-centered.

Technological and Infrastructure Developments

The use of general videoconferencing and teleconferencing apps like Skype and Zoom has become common for remote interactions between patients and healthcare providers. Developers are creating advanced telehealth platforms and mobile applications to provide comprehensive services, including online consultations, lab result checks, and appointment scheduling.

In summary, the article discusses the rapid growth of telemedicine in the MENA region, propelled by technological advancements, government support, and the pressing need for more accessible healthcare. While challenges remain, the overall outlook for telemedicine is positive, with it set to play a crucial role in the future of healthcare in the region.

Reference url

Recent Posts

Health Investment Returns: Harnessing Health as a Strategic Economic Asset

By João L. Carapinha

November 18, 2025

Health as a Strategic Economic Imperative A country's enduring strength stems not solely from military or industrial resources but from the vitality and productivity of its populace. A recent EFPIA Guest Blog by Michael Oberreiter frames he...
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gram-Negative Infections
Emblaveo Approved for MDR Gram-Negative Infections Emblaveo MDR infections pose a growing threat in Portugal, with the public assessment report evaluating Emblaveo (aztreonam + avibactam) for financing under Decree-Law No. 97/2015....
Navigating Targeted Therapy Access: Innovations and Challenges in High-Cost Treatments

By João L. Carapinha

November 14, 2025

Evolving Landscape of Targeted Therapies and Access Challenges Expanding targeted therapy access remains a critical challenge amid the pharmaceutical market's shift toward high-cost innovations, such as orphan drugs and...